BTSG · BrightSpring Health Services, Inc.

Track BTSG — free

$58.87 -0.66 (-1.11%) At close · Aug 21

Market Cap

$11.78B

197.86M

Up next

Next earnings call

Oct 29, 2026 Est · unconfirmed · in 10 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Jul 31, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Sell Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol High

Market backdrop VIX 15.1 · calm Equity put/call 0.51

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg +21%

above

Price vs 50-day avg −11%

below

RSI (14) 40

neutral

MACD trend Negative

52-week position 71%

mid-range

Momentum

relative strength

Strong

1-month return −19%

trailing

6-month return +42%

trailing

YTD return +57%

this year

Relative strength +30%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $66 › 200d $49 — 50d above 200d

Institutional flow Accumulating

+24% holders QoQ · +128 funds added

Insider flow Distributing

Net -$1.7B over 90 days · 100% sells

Short interest Falling

4.25% of float · ▼ -15.7% MoM · 1.5 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

436 holders — near 2-yr high, broad support

Squeeze score 37

low risk · 0–100

Fundamentals

Strong

Revenue growth +28%

Y/Y

Gross margin 12%

contracting

EPS growth +1067%

Y/Y

Free cash flow $394.7M

Valuation P/E 36.1

below peers

Balance sheet $2.4B

net debt

Quant / Vol

risk profile

High

Volatility 44%

annualized · 1-yr

Max drawdown −21%

past year

ATR 4.7%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Jul 31, 2026

Revenues · full year 2026 Initiated $15.1B – $15.43B

prior FY $12.91B midpoint +18.2% Y/Y

Pharmacy Segment Revenue · full year 2026 Initiated $13.2B – $13.5B

Total Adjusted EBITDA · full year 2026 Non-GAAP Initiated $820M – $845M

Provider Segment Revenue · full year 2026 Initiated $1.9B – $1.93B

Prior guidance period ended · from the 8-K filed Oct 28, 2025

Revenues · Full Year 2025 $12.5B – $12.8B

Pharmacy Segment Revenue · Full Year 2025 $11.05B – $11.3B

Provider Segment Revenue · Full Year 2025 $1.45B – $1.5B

Adjusted EBITDA · Full Year 2025 $605M – $615M

Guided vs delivered · last 1 settled

Revenues Full Year 2025

guided $12.5B – $12.8B

guided $12.5B – $12.8B $12.91B Beat +2.1%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

2 · 3 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+21% Bullish

Price vs 50-day avg

−11% Bearish

RSI (14)

40 Neutral

MACD trend

Negative Bearish

52-week position

71% Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $66 › 200d $49 — 50d above 200d

Institutional flow Accumulating

+24% holders QoQ · +128 funds added

Insider flow Distributing

Net -$1.7B over 90 days · 100% sells

Short interest Falling

4.25% of float · ▼ -15.7% MoM · 1.5 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

436 holders — near 2-yr high, broad support

Price context

position in its 52-week range

Range low $24 Now $59 · 71% Range high $73

vs 200-day avg +21% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDA non-GAAP	$395.27M	Six months ended June 30, 2026	—

Gross Profit per script	$27.5	Three Months Ended June 30, 2026	—

Home Health Care average daily census	46,448	Three Months Ended June 30, 2026	—

Personal Care persons served	16,357	Three Months Ended June 30, 2026	—

Pharmacy Solutions segment EBITDA non-GAAP	$180M	Three Months Ended June 30, 2026	—

Prescriptions dispensed	10,844,038	Three Months Ended June 30, 2026	—

Provider Services segment EBITDA non-GAAP	$75M	Three Months Ended June 30, 2026	—

Rehab Care persons served	7,755	Three Months Ended June 30, 2026	—

Revenue per script	$314.2	Three Months Ended June 30, 2026	—

Total Company Adjusted EBITDA non-GAAP	$206M	Three Months Ended June 30, 2026	—

Total Segment Adjusted EBITDA non-GAAP	$255M	Three Months Ended June 30, 2026	—

Leverage non-GAAP	2.27	as of March 31, 2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Health Information Services — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
BTSG BrightSpring Health Services, Inc. this stock	$11.78B	+57.2%	+28.2%	36.1	4.2%
VEEV Veeva Systems Inc	$40.27B	+11.1%	+28.1%	44.0	4.5%
TEM Tempus AI, Inc.	$13.12B	+23.1%	+83.4%	—	18.4%
PMDIY Pro Medicus Ltd./ADR	$13.02B	-24.9%	—	—	0.0%
HQY Healthequity, Inc.	$8.82B	+15.1%	+28.7%	39.5	5.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

436

% held: 106.7%
Net QoQ: -2.5M sh
Top holder: Kohlberg Kravis Roberts &…

Held Float

View

Held by Funds

Fund positions

465

View

Short & Settlement

Short Interest Falling

Shares short

8.4M

Days to cover: 1.5d
Change: -1.6M sh

View

Short Volume

Short vol %

55%

As of: Aug 21, 2026

Short Total

View

Fails to Deliver

FTD shares

358

Value: $25.0K
As of: Jul 24, 2026

View

Off-Exchange

Off-exchange %

50.7%

Week of: Jul 13, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$1.7B

Buyers / Sellers: 0 / 5

Buyers Sellers

View

Financials

Revenue (FY)

$12.9B

Net income (FY): $190.7M
EPS diluted: $0.87

View

Filings

SEC Filings

Latest

8-K

Filed: Jul 31, 2026
This year: 14

View

Proposed Sales

Value

$3.8M

Shares: 62.6K
Filed: Jun 3, 2026

View

Exempt Offerings

Offering

$30.0M

Filed: Sep 16, 2024

View

Earnings & Events

Earnings Calls

Last call

Jul 31, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
BTSG	-4.6%	-19.3%	+41.6%	-1.4%	+57.2%
SPY	-1.4%	+3.6%	+11.6%	+2.5%	+12.3%
vs SPY	-3.2%	-22.9%	+30.0%	-3.9%	+44.9%

Key facts CIK 1865782 CUSIP 10950A106 13F (30d) 394 filings 390 filers Visit website Investor relations

BTSG · BrightSpring Health Services, Inc.

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance